A real-world analysis of survival and cost-effectiveness of sintilimab plus bevacizumab biosimilar regimen in patients with advanced hepatocellular carcinoma

por Zeng, Xianghua, Jia, Yingxin, Chen, Hongmei, Luo, Qinli, Zhao, Huakan, Liang, Guanzhong, Chen, Wen, Li, Yongsheng
Publicado 2023

Circular RNA MYLK Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer Cells by Sponging miR-195-5p and Increasing Glucose Transporter Member 3 Expression

por Xiong, Shuanglong, Li, Dairong, Wang, Donglin, Huang, Lumi, Liang, Guanzhong, Wu, Zhijuan, Long, Jianlin, Yang, Dan, Teng, Yan, Lei, Shuangyi, Li, Yan
Publicado 2020

Efficacy and safety of original EGFR-TKI combined with bevacizumab in advanced lung adenocarcinoma patients harboring EGFR-mutation experiencing gradual progression after EGFR-TKI...

por Long, Jianlin, Lei, Shuangyi, Wu, Zhijuan, Xiong, Shuanglong, Wang, Chunmei, Huang, Lumi, Liang, Guanzhong, Yang, Dan, Teng, Yan, Li, Yongsheng, Qi, Jun, Li, Dairong
Publicado 2022